Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Oncogene
|
March 29, 2006
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia
A M Jubb, S Chalasani, G D Frantz, et al.
Clinical and Translational Radiation Oncology
|
August 25, 2025
Microscopic intramural spread in patients with rectal cancer after neoadjuvant chemoradiation
A E Verrijssen, E J Van Limbergen, M Bellezzo, et al.
British Journal of Cancer
|
January 25, 2014
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
X Su, P Zhan, P R Gavine, et al.
British Journal of Cancer
|
November 13, 2008
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
T E Buffart, R M Overmeer, R D M Steenbergen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2018
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
L C Hewitt, I Z Inam, Y Saito, et al.
British Journal of Cancer
|
August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
J Feilchenfeldt, Z Varga, M Siano, et al.
British Journal of Cancer
|
February 27, 2014
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
G H Bain, E Collie-Duguid, G I Murray, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 4, 2020
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer
K G P Kerckhoffs, D H W Liu, L Saragoni, et al.
British Journal of Cancer
|
March 21, 2013
KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study
N C T van Grieken, T Aoyama, T Aoyma, et al.
ESMO Open
|
May 14, 2024
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
M A Baxter, L C Spender, D Cairns, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Oncogene
|
March 29, 2006
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia
A M Jubb, S Chalasani, G D Frantz, et al.
Clinical and Translational Radiation Oncology
|
August 25, 2025
Microscopic intramural spread in patients with rectal cancer after neoadjuvant chemoradiation
A E Verrijssen, E J Van Limbergen, M Bellezzo, et al.
British Journal of Cancer
|
January 25, 2014
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
X Su, P Zhan, P R Gavine, et al.
British Journal of Cancer
|
November 13, 2008
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
T E Buffart, R M Overmeer, R D M Steenbergen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2018
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
L C Hewitt, I Z Inam, Y Saito, et al.
British Journal of Cancer
|
August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
J Feilchenfeldt, Z Varga, M Siano, et al.
British Journal of Cancer
|
February 27, 2014
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
G H Bain, E Collie-Duguid, G I Murray, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 4, 2020
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer
K G P Kerckhoffs, D H W Liu, L Saragoni, et al.
British Journal of Cancer
|
March 21, 2013
KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study
N C T van Grieken, T Aoyama, T Aoyma, et al.
ESMO Open
|
May 14, 2024
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
M A Baxter, L C Spender, D Cairns, et al.
Page
of 3